Roche’s (JOBS) Avastin Shows Promise in Early Brain Cancer-Study

Reuters -- Roche's Avastin showed promise in delaying the the progress of brain cancer in newly diagnosed patients when it was added to current standard therapies, according to data from a mid-stage clinical study.